Transplant Patients Clinical Trial
Official title:
Virtual Interactive Platform (VIP) Transplant Research Study
The purpose of this study is to test a tablet-based application called VIP Transplant, devised to improve the recovery experience of patients that have recently had organ transplant surgery. The study will consist of two non-randomized arms: the first arm will consist of usual care and the second will be using the newly developed app for 21 days to replace their in-person visits. Using questionnaires and in-app usage metrics, the research team will track whether patients have a better medical outcome, greater patient satisfaction with care, and greater compliance rates as compared to patients who do not use VIP Transplant to manage their care.
An organ transplant requires a large time and financial investment for both the patient and
provider over the course of a lifetime of follow-up visits and lifestyle monitoring. Patients
return to the clinic 2-3 times a week for the first three months after surgery, and then
visit the clinic twice a month with labs once a week 91-210 days post surgery. Check-ins for
patients without complications occur 1-2 times a year, and these re-evaluations require
patients to take time off work and travel to the transplant center often 2 hours away. Dr.
David Mulligan, Chief of Transplant at Yale wanted to help patients reduce the time and cost
associated with their regular checkups after surgery. Thus, we created VIP Transplant. The
Virtual Interactive Platform allows patients to have a secure videoconference with their
provider in order to eliminate the need for recurring travel and waiting in congested clinics
for a short appointment. It will save patient time and cost to travel to the clinic. The
application is integrated into the provider network in order to have a system that supports
seamless communication between the patient and provider capabilities.
Research plan:
Dr. Mulligan will contact 8 of his patients who are willing to participate in the study. 4 of
the patients will be assigned to the control group and the other 4 will be assigned to the
experimental group.
Control group:
On day 1 after their surgery, patient will be asked to fill out a survey on their transplant
care. On day 21, patient will be asked to fill out the same survey. The surgeon will be asked
to take a survey to evaluate their each patient's progress.
Experimental group:
When the 4 patients attend orientation, patient will each be given the iPad with the VIP
Transplant app and shown how to use the app. Patient will then be asked to fill out the
survey on day 1 after their surgery and then asked to use VIP Transplant for their transplant
care in the following days. Patient will then be asked to fill out the survey again on day
21, at the end of the study. The surgeon will be asked to take a survey to evaluate each of
their patient's progress.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT02377609 -
To Validate an Analytical Method to Measure Concentration of Tacrolimus in Blood Taken From Finger Pricks
|
N/A |